Oracles, Billion

Oracle's $70 Billion Infrastructure Bet Is Spooking Investors More Than Its Record Revenue

12.06.2026 - 15:32:04 | boerse-global.de

Despite 21% revenue jump and $638B backlog, Oracle stock drops on $70B capex plan and $40B new financing, reflecting market shift from demand to cash flow proof.

Oracle's Record Quarter Overshadowed by AI Infrastructure Spending and Dilution Fears
Oracles - Oracle's $70 Billion Infrastructure Bet Is Spooking Investors More Than Its Record Revenue 12.06.2026 - Bild: ĂĽber boerse-global.de

Oracle turned in a quarter that by almost any conventional measure was stellar: revenue jumped 21% to $19.2 billion, cloud infrastructure revenue surged 93%, and the company’s remaining performance obligations — signed contracts yet to be recognised as revenue — hit an eye-popping $638 billion, up 363% from a year earlier. Yet the stock has shed roughly 15% in the past seven days and sits at €158.50, some 43% below its 52-week high of €280.70. The disconnect between a record quarter and a falling share price tells a story about where the market’s patience ends.

The trouble lies not in Oracle’s ability to win business — four individual customers each contracted more than $8 billion during the quarter, with OpenAI alone accounting for over half of those obligations — but in the cost of delivering on those promises. In its most recent fiscal year, the company posted negative free cash flow of $23.7 billion as capital expenditure ballooned 162% to $55.7 billion. And the bill is only getting larger: management has pencilled in roughly $70 billion in net capital expenditure for fiscal 2027. When customer prepayments and timing effects are added, the gross figure swells by another $20 billion to $25 billion.

To bankroll that expansion, Oracle raised $43 billion in debt and $5 billion in equity during the past fiscal year. For 2027, it plans a further $40 billion in combined debt and equity financing, including a pre-announced $20 billion equity issuance. That dilution prospect is what sent the shares lower — not a revenue miss that never materialised. The market is effectively asking whether the massive backlog can be converted into cash flow fast enough to justify the capital being poured into AI data centres.

The sell-off is not Oracle-specific. It reflects a broader recalibration of how investors value AI infrastructure. Two years ago, contracted demand was enough; today the market wants proof of cash generation. The trigger came from Broadcom: a modest shortfall in its AI revenue outlook wiped more than $1.3 trillion in market capitalisation from the global semiconductor sector in a single day. CEO Hock Tan held to his 2027 chip forecast rather than raising it, and in an environment where growth is mandatory, that landed like a quiet admission that momentum is fading. Contagion swept across AI-linked names — Oracle among them.

Should investors sell immediately? Or is it worth buying Oracle?

Adding to the pressure, Oracle’s gross margins are being squeezed by the ramp-up of new data centres. The company expects further margin decline in 2027 purely because infrastructure must be built before it can be filled. Management argues that margins will improve significantly once the data centres reach full contractual utilisation. The market, for now, is not in a mood to wait.

A structural argument does exist for Oracle that the current sell-off obscures. The company positions itself not as a walled-off ecosystem but as a neutral data backbone that runs across all major cloud platforms. Oracle Cloud Infrastructure is physically embedded inside AWS, Google Cloud and Microsoft Azure, enabling low-latency, natively integrated database services. The trend toward sovereign cloud — where governments require data to stay within national borders — also plays to Oracle’s flexible deployment model. The company builds dedicated regions for individual states, and in markets where AWS or Azure face regulatory pressure, Oracle can pick up government contracts. The US Personnel Authority, for example, is paying nearly $400 million for IT system modernisation.

Analyst views are unusually divided. Deutsche Bank, Jefferies and J.P. Morgan reaffirmed buy ratings after the results; Guggenheim holds a $400 price target. RBC, however, cut its target from $310 to $250 and stayed at “sector perform”. Of 43 analysts polled by S&P Global, the consensus is still “buy”, but the target range of $250 to $400 reflects genuine uncertainty around how quickly Oracle can turn its backlog into recognised revenue and profit.

Oracle at a turning point? This analysis reveals what investors need to know now.

Technically, the stock is trading almost exactly on its 50-day moving average of €158.26 — neither broken nor recovered. The RSI of 41.9 signals pressure but not panic. The 200-day moving average at €176.84, roughly 10% above the current price, marks the first meaningful resistance. Management has guided for a revenue CAGR of 31% and an earnings CAGR of 28% through 2030. That is a long-term promise in a market that currently measures patience in quarters, not years. Oracle may well deliver on that promise — but until the cash flow turns positive, a record quarter looks like just another reason to sell.

Ad

Oracle Stock: New Analysis - 12 June

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

en | US68389X1054 | ORACLES | boerse | 69527875 |